Acadia Healthcare Company, Inc. $ACHC is Khrom Capital Management LLC's 7th Largest Position

Key Points

• Khrom Capital Management LLC has increased its stake in Acadia Healthcare by 26.9%, making it the firm's 7th largest position, with an ownership of over 1.5 million shares valued at approximately $48.1 million.
• Several institutional investors have significantly raised their positions in Acadia Healthcare, including Caitong International Asset Management, which saw a staggering increase of 11,218.2% in the first quarter.
• Acadia Healthcare recently reported earnings that exceeded estimates with a revenue of $869.23 million and an EPS of $0.83, prompting analysts to maintain a "Moderate Buy" rating with a consensus price target of $40.77.

Khrom Capital Management LLC raised its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 26.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,587,299 shares of the company's stock after purchasing an additional 336,297 shares during the period. Acadia Healthcare accounts for 6.4% of Khrom Capital Management LLC's portfolio, making the stock its 7th largest position. Khrom Capital Management LLC owned about 1.72% of Acadia Healthcare worth $48,127,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd raised its position in shares of Acadia Healthcare by 11,218.2% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after buying an additional 1,234 shares during the period. UMB Bank n.a. raised its holdings in shares of Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the period. State of Wyoming acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at about $56,000. Covestor Ltd grew its holdings in shares of Acadia Healthcare by 56.0% during the 1st quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after purchasing an additional 812 shares during the period. Finally, Aquatic Capital Management LLC purchased a new position in Acadia Healthcare in the fourth quarter valued at approximately $97,000.

Analyst Upgrades and Downgrades

ACHC has been the subject of several recent research reports. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Sunday, August 3rd. Barclays reduced their price objective on Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 7th. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Cowen restated a "buy" rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Finally, Mizuho dropped their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 13th. Nine research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $40.77.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $22.96 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market cap of $2.12 billion, a P/E ratio of 15.21, a P/E/G ratio of 4.52 and a beta of 0.88. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $82.40. The firm has a fifty day moving average of $22.01 and a two-hundred day moving average of $25.44.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. During the same quarter last year, the firm earned $0.91 EPS. The business's revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.